A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors

Clinical trial NCT07328217 · RECRUITING

Trial details

NCT number: NCT07328217
Sponsor: Dizal Pharmaceuticals
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2026-01-29
Primary completion: 2028-12-01
Enrollment: 203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.